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Abstract S100, a subfamily of the EF-hand type calcium
sensing proteins, is implicated in many cellular functions
including muscle contractility. Two isoforms, S100A1 and
S100B, at 2^10 WM significantly inhibit active tension, stiffness
and ATPase of skinned single rabbit psoas muscle fibers at sub-
maximal (pCaV6.1-5.6), but not at maximal levels of activation
(pCa 4.0). S100A1 is a more potent inhibitor than S100B. Hill
analysis of the ATPase^pCa and tension^pCa curves indicates
that these proteins reduce calcium sensitivity and enhance the
cooperativity toward calcium. We propose S100A1, and perhaps
S100B, are viable candidates as physiological modulators of
muscle contraction. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
The S100s are a subfamily of the EF-hand type of calcium
sensing proteins that have been implicated in a multitude of
cellular functions and diseases, including muscle contractility
(reviewed in [1,2]). Two isoforms, S100A1 (20.8 kDa) and
S100B (21 kDa), which occur as dimers of identical subunits
with two EF-hand calcium-binding motifs per subunit, are
particularly strong candidates for physiological modulation
of muscle function. These proteins interact with the proteins
in the sarcomere and are present in signi¢cant amounts in
skeletal and cardiac muscles [3^7]. They are also capable of
modulating smooth muscle actin^myosin interaction in the
presence of the regulatory proteins caldesmon or calponin
[8^10]. Furthermore, both isoforms are implicated in the nor-
mal development [11,12] and functioning of the heart ^ the
expression of S100A1 is reduced in human cardiomyopathy
[13] and increased in hypertrophy-induced right ventricles [14],
and S100B is capable of regulating cardiac hypertrophy [15].
In order to determine potential roles of the S100s in con-
tractility of skeletal muscle, we have examined the e¡ect of
S100A1 and S100B on the calcium activation of isometric
tension, sti¡ness and ATPase in chemically and mechanically
skinned single rabbit psoas muscle ¢bers. At physiological
levels of concentration (2^10 WM), both proteins desensitized
the activation of tension, sti¡ness, and ATPase in parallel
without signi¢cantly altering the maximum values. Interest-
ingly, the inhibition by S100A1 was much greater than by
S100B, indicating an isoform-speci¢c function of S100A1.
2. Materials and methods
2.1. Doubly skinned ¢ber preparation
Chemically skinned psoas ¢ber bundles were prepared from adult,
white New Zealand rabbits (V2 kg) as described [16]. Single ¢bers
were dissected from bundles in rigor solution (10 mM imidazole, 12
mM potassium ethylene glycol-bis(L-amino-ethyl ether)-N,N,NP,NP-
tetraacetic acid (K-EGTA), 1.3 mM Mg-acetate, 138 mM potassium
propionate (KPr), 1 mM dithiothreitol (DTT), 20 Wg/ml leupeptin, pH
7.0), and the sarcolemma of a V5 mm segment was peeled o¡ with
tweezers (Dumont #5) under a dissecting microscope (SZ60, Olym-
pus). All experiments were carried out at or near the slack sarcomere
length (SL) = 2.1^2.2 Wm by allowing the ¢ber to buckle ¢rst
(V30 min), followed by slow stretching until the force began increas-
ing just above the baseline level.
S100A1 and S100B were procured in lyophilized form (bovine brain
source, Sigma). Prior to use, the identity and the purity (s 95%) were
routinely veri¢ed by matrix-assisted laser desorption ionization^time
of £ight mass spectroscopy and sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis, respectively. The protein concentrations
were determined from absorbance at 280 nm using extinction coe⁄-
cients (mg/ml) of 0.91 and 0.20 for S100A1 and S100B [17,18].
2.2. Muscle mechanics
Two mechanical setups were used. Tension and sti¡ness were mea-
sured in a previously described setup with modi¢cations [19]. The
force transducer (Ackers, model AE 801E, Horten, Norway) and
the length transducer (Cambridge Technology, Inc., model 300S,
Cambridge, MA, USA) were mounted over a sample chamber on
top of an inverted microscope. Stainless steel pin-hooks were attached
to the transducers for ¢ber mounting via aluminum ‘T-clips’. The SL
was monitored continuously by focusing the ¢rst order di¡raction
spots from the ¢ber on a linear photo-diode array that was calibrated
with gratings of known spacing. In-house developed software was
used to acquire data and control the instrument. Sti¡ness (the ratio
of amplitudes of tension and percent ¢ber length) was acquired by the
sinusoidal method at 2 kHz with a 0.1% of ¢ber length amplitude and
16 sine waves. The ¢ber cross-sectional area was calculated from the
average of 4^8 equidistant measurements along ¢ber axis at a magni-
¢cation of 400U.
The free calcium concentrations in the relaxing solution (pCas 8,
10 mM imidazole, 12 mM K-EGTA, 3 mM Mg-acetate, 117 mM
KPr, 1.8 mM sodium adenosine 5P-triphosphate, 5 mM phosphocrea-
tine (CP) and 200 U/ml of creatine phosphokinase (CPK), 1 mM
DTT, 20 Wg/ml leupeptin, pH 7.0) and the activating solution (pCa
4, same as relaxing solution except with 2.5 mM Mg-acetate and with
K-EGTA replaced with Ca-EGTA) were routinely measured. In the
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activating solution of pCa 5.7, obtained by mixing appropriate
amounts of the relaxing and activating solutions, the pCa electrode
measurement (see below) showed no change in pCa upon the addition
of 80 WM S100A1 or S100B, thus ruling out changes in free calcium
by the S100s.
Simultaneous measurements of tension and ATPase over the entire
calcium activation range were done with a commercial instrument
(K. Guth, Scienti¢c Instruments, Heidelberg, Germany). The relaxing
and activating solutions in this setup contained 0.4 mM nicotinamide
adenine dinucleotide (NADH), 140 U/ml L-lactic dehydrogenase,
100 U/ml pyruvate kinase, and 5 mM phosphoenolpyruvate for the
enzyme-coupled assay [20] in lieu of the CP and CPK, with ionic
strength adjusted by KPr. pCa of solution at the ¢ber was varied
by mixing these solutions with a gradient mixer. The actual pCa at
the ¢ber was monitored using a £uorescent calcium indicator, Calci-
um Green II (Molecular Probes) and veri¢ed with a calcium selective
electrode (Orion Research Inc., Beverly, MA, USA) previously cali-
brated with calcium standards (WPI, Sarasota, FL, USA). The ATP-
ase was determined using the £uorescence decay of NADH in an
enzyme-linked assay system [20].
To account for variability between ¢bers and conditions, each set of
experiments were carried out on the same day with the same ¢ber and
the same solutions. The tension/pCa and ATPase/pCa curves were
¢tted with the Hill equation using the non-linear ¢tting routine (Lev-
enberg^Marquardt) in MathCAD, version 8.0 (MathSoft, Inc.):
y = ymax/(1+10npCa3pK), where ymax is the maximum value, n is the
Hill coe⁄cient and pK is the calcium concentration in pCa units
where the measured quantity (y) is at 50% of ymax.
3. Results
3.1. Inhibition of isometric tension and sti¡ness by S100
Both S100A1 and S100B exhibit a concentration-dependent
and reversible inhibition of tension and sti¡ness at pCa 5.7, a
sub-maximal calcium activation level. As shown for S100A1
in Fig. 1A, incremental increase of S100A1 from 1 to 4 WM
(downward arrows) resulted in a signi¢cant inhibition of both
tension and sti¡ness, up to 60% at 4 WM, and appeared to
plateau at 60^70% beyond 10 WM (data not shown). The e¡ect
was rapid, observed within 20 s of the addition, and revers-
ible, as shown by the rapid recovery of tension and sti¡ness
upon treating the ¢ber with activating solution. Sti¡ness var-
ied in parallel with tension over the entire trace in Fig. 1A.
Repeated cycles of application and removal of S100 proteins
resulted in qualitatively similar inhibition (data not shown).
However, neither S100A1 nor S100B produced a signi¢cant
change in the tension and sti¡ness measurements under max-
imum calcium activation (pCa 4.0) and under either rigor or
relaxing conditions (data not shown).
Measurements at pCa 5.7 and 4.0 from 23 separate ¢bers
were normalized, averaged and summarized in Fig. 1B,C.
Compared to values in the absence of the proteins, the relative
tension and sti¡ness at pCa 5.7 under the saturating concen-
trations of S100 (v10 WM) were, respectively, 0.41 þ 0.07
(n = 9) and 0.52 þ 0.07 (n = 20) for S100A1 and 0.76 þ 0.03
(n = 5) and 0.75 þ 0.04 (n = 5) for S100B. Based on Student’s
t-test, the inhibitions for both S100s became signi¢cant only
at the sub-maximal activation at pCa 5.7 (PI0.05) but not at
pCa 4.0. Thus, the S100A1 isoform appears to be a potent
inhibitor of ¢ber mechanics at sub-maximal activation levels,
while S100B appears to have a lesser e¡ect.
3.2. Desensitization of calcium activation of tension and
ATPase
The calcium dependence of the inhibition was explored fur-
ther by simultaneously measuring the tension^pCa and ATP-
ase^pCa curves over the entire range of activation. Figs. 2 and
3 show the representative data sets of tension- and ATPase^
pCa curves that are analyzed with the Hill equations for the
sensitivity and the degree of cooperativity of activation.
S100A1 (at 6 and 10 WM) caused a signi¢cant shift of the
curves towards lower pCa (therefore lowered calcium sensitiv-
ity) : pK reduced from 5.95 to 5.88 (6 WM) and to 5.78 (10 WM)
for the ATPase curves and 5.88 to 5.83 (6 WM) and to 5.71
(10 WM) for the tension curves (Fig. 2). A somewhat increased
cooperativity, as re£ected by the larger Hill coe⁄cients, was
also observed. n Increased from 6.8 to 7.9 (6 WM) but was
unchanged at 10 WM for the ATPase curves and it increased
from 9.3 to 10.4 (6 WM) and to 10.6 (10 WM) for the tension
curves. The changes for S100B (at 10 WM) were much smaller,
yet reproducible, as demonstrated by the highly precise mea-
surements (Fig. 3). The pKs changed from 5.84 to 5.81 for the
ATPase curve and from 5.79 to 5.75, for the tension curve.
Hill coe⁄cients in the presence of S100B also increased
slightly: an increase from 8.7 to 9.1 for the ATPase curve
and 8.8 to 9.4 for the tension curve (Fig. 3).
4. Discussion
The present data demonstrate for the ¢rst time that the
Fig. 1. Inhibition of isometric tension and sti¡ness by S100A1 and
S100B. A: A doubly skinned single ¢ber (2.0U95 Wm, SL = 2.1 Wm)
in relaxing solution (R) was initially activated in activating solution
at pCa 5.7 (Ac) and S100A1 was added in 1 WM increments at the
arrows, followed by treatment with the activating solution (Ac). The
spikes in tension, shown in lighter shade, are artifacts due to the so-
lution exchanges. B and C: Relative tension (dark bars) and sti¡-
ness (lighter bars) at pCa 5.7 and 4.0 in the presence of S100A1
and S100B with error bars (S.E.M., n = 2^19). Fiber diameter = 64^
83 Wm, SL = 2.1 Wm, S100 = 5^20 WM. All comparisons were made
in the same ¢ber and then averaged among the di¡erent ¢bers.
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S100 proteins at 2^10 WM reversibly inhibit isometric tension
and sti¡ness in skinned rabbit skeletal muscle. These proteins
lower the sensitivity and enhance the cooperativity of both
tension and ATPase toward calcium (i.e. a shift of pKs toward
lower pCa and an increase of Hill coe⁄cient) without signi¢-
cant changes at maximal levels of activation. The signi¢cantly
higher potency of S100A1 inhibition compared to S100B,
combined with the higher abundance of S100A1, suggests a
strong physiological relevance for S100A1 in skeletal muscle
function.
Although the S100 content in rabbit psoas ¢bers is not
currently available, the estimated content by immunoassay
methods is V1 Wg for S100A1 per mg of wet tissue in human
skeletal muscle [21,22]. S100A1 content varies with the ¢ber
type, and is 3-fold lower (V0.3 Wg/mg of wet tissue) in the
fast-twitch than in the slow-twitch in mice [5]. Assuming 1 g
of wet muscle occupies 1 ml volume, these values convert to
V50 WM and V15 WM, respectively, in the two ¢ber types.
Thus, the S100A1-induced modulation of activation demon-
strated here is physiologically signi¢cant. S100B is reportedly
lower (yet unspeci¢ed) in content than S100A in human skel-
etal muscle [22]. Its lower potency of inhibition and lower
content obscure the physiological relevance of this isoform
in skeletal muscle activation.
Our observation that inhibition of tension is accompanied
by parallel inhibitions of sti¡ness and ATPase in skinned ¢-
bers indicates a direct inhibition of the interaction between
actin and myosin by the S100s. Several potential mechanisms
are plausible. The trivial possibility that the observed e¡ects
are due to an exchange of S100 with other EF-hand proteins
in the ¢ber, such as troponin C (TnC) and myosin light
chains, is excluded by the following observations. (a) the
S100 e¡ects are much more rapid than the lengthy and drastic
procedures required for the exchange of analogous proteins
with TnC or light chains [23,24], and (b) the inhibition was
rapidly reversed upon removal of the added protein by bu¡er,
Fig. 2. Desensitization of calcium activation of tension and ATPase
by S100A1. The relative ATPase (open symbols) and tension (closed
symbols) from doubly skinned single ¢bers are plotted as a function
of solution pCa. The lines are ¢t to the data using the Hill equation
with the parameters shown next to the ¢gures. Top: without
S100A1; middle: 6 WM S100A1; bottom: 10 WM S100A1, T = 23‡C,
SL = 2.1 Wm.
Fig. 3. Desensitization of calcium activation of tension and ATPase
by S100B. The relative ATPase (open symbols) and tension (closed
symbols) from doubly skinned single ¢bers are plotted as a function
of solution pCa. Two sets of activation data are shown for each
condition to show repeatability. The lines are ¢t to the one set of
data using the Hill equation with the parameters shown next to the
¢gures. Top: without S100B; bottom: 10 WM S100B, T = 23‡C,
SL = 2.1 Wm.
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indicating no loss of endogenous proteins. In principle, a di-
rect blocking of the molecular interface between actin and
myosin by the S100s could produce the inhibitions. Indeed,
both S100s are known to bind to CapZK [25,26] and the
PEVK fragment of titin [27]. S100A1 also binds to myosin
heavy chain [7] and F-actin [28]. However, S100A1 does not
directly alter the actin-activated ATPase activities of either the
skeletal muscle myosin or the thiophosphorylated smooth
muscle myosin in solution [10,29]. Therefore, it is necessary
to invoke protein interactions that involve additional regula-
tor(s) that control actin and myosin interactions to explain
these inhibitions. In this connection, two observations are in-
triguing: (a) the calcium-regulated binding of S100A1 to F-
actin [28], and (b) the capability of the S100s to modulate
actin^myosin interactions in the presence of secondary regu-
latory proteins, such as smooth muscle caldesmon and calpo-
nin [8^10]. Since these regulatory proteins are thought to
function analogously to nebulin in skeletal muscle [30], we
speculate that the S100s may interact simultaneously with
nebulin and actin in a calcium-dependent manner and regulate
the interaction of myosin with the thin ¢lament. This is a
potentially signi¢cant role for the S100s in muscle, in addition
to the multitude of other functions implicated from previous
studies [1,2].
In summary, S100A1 and perhaps S100B are capable of
modulating contractility at physiological concentrations by
desensitizing the calcium activation of skeletal muscle. Such
a modulation represents a distinct and heretofore unappreci-
ated branch of the calcium signaling pathways in skeletal
muscle.
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